Marina Novoselova

Dr. Marina Novoselova

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
MNMarina Novoselova
Marina Novoselova
SGSergei V. German
Sergei V. German
TATatiana O. Abakumova
Tatiana O. Abakumova
SPStanislav V. Perevoschikov
Stanislav V. Perevoschikov
OSOlga V. Sergeeva
Olga V. Sergeeva
DGDmitry A. Gorin
Dmitry A. Gorin

1 September 2019 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
MNMarina Novoselova
Marina Novoselova
DVDenis V. Voronin
Denis V. Voronin
TATatiana Abakumova
Tatiana Abakumova
PDPolina A. Demina
Polina A. Demina
APArsenii V. Petrov
Arsenii V. Petrov
Dmitry GorinDmitry Gorin
Dmitry Gorin

10 July 2018 in Biotechnology Journal
Verified
Journal Article
Closed access
PDF file
Anatolii AbalymovAnatolii Abalymov
Anatolii Abalymov
RVRoman Verkhovskii
Roman Verkhovskii
MNMarina Novoselova
Marina Novoselova
BPBogdan Parakhonskiy
Bogdan Parakhonskiy
Dmitry GorinDmitry Gorin
Dmitry Gorin
Gleb SukhorukovGleb Sukhorukov
Gleb Sukhorukov

1 December 2020 in Photoacoustics
Verified
Journal Article
Open access
MNMarina Novoselova
Marina Novoselova
TATatiana O. Abakumova
Tatiana O. Abakumova
BKBoris Khlebtsov
Boris Khlebtsov
Timofei ZatsepinTimofei Zatsepin
Timofei Zatsepin
ELEkaterina Nikolaevna Lazareva
Ekaterina Nikolaevna Lazareva
EGEkaterina Galanzha
Ekaterina Galanzha
Photoacoustic (PA) imaging (PAI) is an emerging powerful tool for noninvasive real-time mapping of blood and lymphatic vessels and lymph nodes in vivo to diagnose cancer, lymphedema and other diseases. Among different PAI instruments, commercially available raster-scanning optoacoustic mesoscopy (RSOM) (iThera Medical GmbH., Germany) is useful for high-resolution imaging of different tissues with high potential of clinical translation. However, skin light scattering prevents mapping vessels and nodes deeper than 1–2 mm, that limits diagnostic values of PAI including RSOM. Here we demonstrate that glycerol-based tissue optical clearing (TOC) overcomes this challenge by reducing light scattering that improves RSOM depth penetration. In preclinical model of mouse limb in vivo, the replacement of conventional acoustic coupling agents such as water on the mixture of 70 % glycerol and 30 % ultrasound (US) gel resulted in the increase of tissue imaging depth in 1.5–2 times with 3D visualization of vessels with diameter down to 20 μm. To distinguish blood and lymphatic networks, we integrated label-free PA angiography (i.e., imaging of blood vessels), which uses hemoglobin as endogenous contrast agent, with PA lymphography based on labeling of lymphatic vessels with exogenous PA contrast agents. Similar to well-established clinical lymphography, contrast agents were injected in tissue and taken up by lymphatic vessels within a few minutes that provided quick RSOM lymphography. Furthermore, co-injection of PA contrast dye and multilayer nanocomposites as potential low-toxic drug-cargo showed selective prolonged accumulation of nanocomposites in sentinel lymph nodes. Overall, our findings open perspectives for deep and high resolution 3D PA angio- and lymphography, and for PA-guided lymphatic drug delivery using new RSOM & TOC approach.

25 June 2019 in Polymers
Verified
Journal Article
Open access
PDF file
MNMarina Novoselova
Marina Novoselova
SGSergei German
Sergei German
Olga SindeevaOlga Sindeeva
Olga Sindeeva
OKOleg Alexandrovich Kulikov
Oleg Alexandrovich Kulikov
OMOlga Minaeva
Olga Minaeva
Dmitry GorinDmitry Gorin
Dmitry Gorin
Although new drug delivery systems have been intensely developed in the past decade, no significant increase in the efficiency of drug delivery by nanostructure carriers has been achieved. The reasons are the lack of information about acute toxicity, the influence of the submicron size of the carrier and difficulties with the study of biodistribution in vivo. Here we propose, for the first time in vivo, new nanocomposite submicron carriers made of bovine serum albumin (BSA) and tannic acid (TA) and containing magnetite nanoparticles with sufficient content for navigation in a magnetic field gradient on mice. We examined the efficacy of these submicron carriers as a delivery vehicle in combination with magnetite nanoparticles which were systemically administered intravenously. In addition, the systemic toxicity of this carrier for intravenous administration was explicitly studied. The results showed that (BSA/TA) carriers in the given doses were hemocompatible and didn’t cause any adverse effect on the respiratory system, kidney or liver functions. A combination of gradient-magnetic-field controllable biodistribution of submicron carriers with fluorescence tomography/MRI imaging in vivo provides a new opportunity to improve drug delivery efficiency.

11 February 2022 in ACS Applied Nano Materials
Verified
Journal Article
Closed access
EVEvgeny S. Vavaev
Evgeny S. Vavaev
MNMarina Novoselova
Marina Novoselova
NSNikita Shchelkunov
Nikita Shchelkunov
SGSergei German
Sergei German
AKAleksei Komlev
Aleksei Komlev
Dmitry GorinDmitry Gorin
Dmitry Gorin